BLEMISH DOTS - CHARCOAL (10 PATCHES) .5 g/100g
Salicylic Acid 0.5% · PATCH · MELON BIO-TECH (THAILAND) CO., LTD.
BLEMISH DOTS - CHARCOAL (10 PATCHES) is a patch containing salicylic acid 0.5% at .5 g/100g, taken topical. Manufactured by MELON BIO-TECH (THAILAND) CO., LTD..
Key Facts
- Brand Name
- BLEMISH DOTS - CHARCOAL (10 PATCHES)
- Generic Name
- Salicylic Acid 0.5%
- NDC Code (Product)
85588-121- Manufacturer
- MELON BIO-TECH (THAILAND) CO., LTD.
- Strength
- .5 g/100g
- Dosage Form
- PATCH
- Route
- TOPICAL
- Marketing Status
- Application #
- M006
- Marketing Start
- 05/26/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is BLEMISH DOTS - CHARCOAL (10 PATCHES) used for?
BLEMISH DOTS - CHARCOAL (10 PATCHES) contains Salicylic Acid 0.5%. It is a patch taken topical. Consult your doctor for specific uses.
Is BLEMISH DOTS - CHARCOAL (10 PATCHES) a controlled substance?
BLEMISH DOTS - CHARCOAL (10 PATCHES) is not classified as a controlled substance by the DEA.
What is the generic name for BLEMISH DOTS - CHARCOAL (10 PATCHES)?
The generic name for BLEMISH DOTS - CHARCOAL (10 PATCHES) is Salicylic Acid 0.5%. There are 11 other brand versions of Salicylic Acid 0.5%.
What is the NDC code for BLEMISH DOTS - CHARCOAL (10 PATCHES) .5 g/100g?
The NDC (National Drug Code) for BLEMISH DOTS - CHARCOAL (10 PATCHES) .5 g/100g is 85588-121, listed by MELON BIO-TECH (THAILAND) CO., LTD..
Other BLEMISH DOTS - CHARCOAL (10 PATCHES) Dosages
Other Salicylic Brands
See all →- BLEMISH DOTS - RETINOL (10 PATCHES).5 g/100g85588-122
- Blemish Dots5 g/100g56136-180
- Lacura Blemish Dots Conceal and Treat5 mg/g56136-181
- Blemish Dots.5 g/100g56136-186
- BLEMISH DOTS - RETINOL (10 PATCHES).5 g/100g56136-187
- My Beauty Spot Acne Buster.5 g/100g56136-183
- Blemish Control Dots.5 g/100g56136-184
- my beauty spot BLEMISH DOTS - CHARCOAL (10 PATCHES).5 g/100g56136-195
- CLN ACNE CLEANSER5 mg/mL69530-857
- My Beauty Spot Acne Buster.5 g/100g56136-182
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)